Signal transducer and activator of transcription proteins in leukemias

被引:271
作者
Benekli, M
Baer, MR
Baumann, H
Wetzler, M
机构
[1] Roswell Pk Canc Inst, Dept Med, Leukemia Sect, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA
关键词
D O I
10.1182/blood-2002-04-1204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signal transducer and activator of transcription (STAT) proteins are a 7-member family of cytoplasmic transcription factors that contribute to signal transduction by cytokines, hormones, and growth factors. STAT proteins control fundamental cellular processes, including survival, proliferation, and differentiation. Given the critical roles of STAT proteins, it was hypothesized that inapt propriate. or aberrant activation of STATs might contribute to cellular transformation and, in particular, leukemogenesis. Constitutive activation of mutated STAT3 has in fact been demonstrated to,result in transformation. STAT activation has been. extensively studied in leukemias, and. mechanisms Of STAT activation and the potential role of STAT signaling in leukemogenesis are the focus of this review. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2940 / 2954
页数:15
相关论文
共 262 条
[1]   Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, H ;
Manshouri, T ;
Gidel, C ;
Estey, E ;
Thomas, D ;
Koller, C ;
Estrov, Z ;
O'Brien, S ;
Keating, M ;
Freireich, E ;
Albitar, M .
BLOOD, 2000, 96 (06) :2240-2245
[2]   Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J].
Aguayo, A ;
Estey, E ;
Kantarjian, H ;
Mansouri, T ;
Gidel, C ;
Keating, M ;
Giles, F ;
Estrov, Z ;
Barlogie, B ;
Albitar, M .
BLOOD, 1999, 94 (11) :3717-3721
[3]   Defective IL-2-mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes [J].
Akaishi, H ;
Takeda, K ;
Kaisho, T ;
Shineha, R ;
Satomi, S ;
Takeda, J ;
Akira, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (11) :1747-1751
[4]   Roles of STAT3 defined by tissue-specific gene targeting [J].
Akira, S .
ONCOGENE, 2000, 19 (21) :2607-2611
[5]   Functional roles of STAT family proteins: Lessons from knockout mice [J].
Akira, S .
STEM CELLS, 1999, 17 (03) :138-146
[6]  
Alas S, 2001, CANCER RES, V61, P5137
[7]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[8]   Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid [J].
Andreeff, M ;
Jiang, S ;
Zhang, X ;
Konopleva, M ;
Estrov, Z ;
Snell, VE ;
Xie, Z ;
Okcu, MF ;
Sanchez-Williams, G ;
Dong, J ;
Estey, EH ;
Champlin, RC ;
Kornblau, SM ;
Reed, JC ;
Zhao, S .
LEUKEMIA, 1999, 13 (11) :1881-1892
[9]   The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor α in acute promyelocytic-like leukaemia [J].
Arnould, C ;
Philippe, C ;
Bourdon, V ;
Grégoire, MJ ;
Berger, R ;
Jonveaux, P .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1741-1749
[10]  
Aronica MG, 1996, ONCOGENE, V13, P1017